Impact of Different Traditional Chinese Medicine Constitutions on the Clinical Outcomes of COVID-19 Patients Infected with SARS-CoV-2 Omicron Variant: A Retrospective Observational Study

被引:1
|
作者
Feng, Hui [1 ]
Qiu, Shanhu [2 ]
Hong, Xiang [3 ]
Ma, Shaolei [4 ]
Hou, Zhenghua [5 ]
Zhu, Kongbo [6 ]
Guo, Ming [1 ]
Wang, Changsong [1 ,9 ]
Huang, Yingzi [7 ,8 ]
机构
[1] Southeast Univ, Zhongda Hosp, Sch Med, Dept Tradit Chinese Med, Nanjing, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Inst Diabet, Sch Med,Dept Gen Practice, Nanjing, Peoples R China
[3] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Nanjing, Peoples R China
[4] Southeast Univ, Zhongda Hosp, Sch Med, Dept Emergency & Crit Care Med, Nanjing, Peoples R China
[5] Southeast Univ, Zhongda Hosp, Sch Med, Dept Psychosomat & Psychiat, Nanjing, Peoples R China
[6] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, Nanjing, Peoples R China
[7] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, Nanjing, Peoples R China
[8] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, 87 Dingjiaqiao Rd, Nanjing 210009, Peoples R China
[9] Southeast Univ, Zhongda Hosp, Sch Med, Dept Tradit Chinese Med, 87 Dingjiaqiao Rd, Nanjing 210009, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2023年 / 16卷
关键词
traditional Chinese medicine constitution; COVID-19; SARS-CoV-2 omicron variant; time to negative nucleic acid test; seven-day conversion rate to negative; NEGATIVE CONVERSION; BODY CONSTITUTION; PREDICTORS; MORTALITY; TIME;
D O I
10.2147/IDR.S424176
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: Traditional Chinese Medicine (TCM) constitution and disease occurrence, development, and prognosis are interrelated. This study aimed to investigate the association between TCM constitution and the time to negative nucleic acid test results in patients with coronavirus disease 2019 (COVID-19) infected with the SARS-CoV-2 Omicron variant.Patients and Methods: We identified COVID-19 patients (>= 18 years) infected with the SARS-CoV-2 Omicron variant and collected clinical data, including clinical symptoms, time to negative nucleic acid test results, and TCM constitution. Linear and logistic regression analyses explored the relationship between TCM constitution and the time to negative nucleic acid test results in patients with the COVID-19 Omicron variant.Results: We included 486 patients with COVID-19, with a mean age of 40.2 years; 321 (66.0%) men and 165 (34.0%) women. Balanced constitution accounted for 43.8%, and unbalanced constitution accounted for 56.2%. Chi-square test showed that different TCM constitutions had significant differences in the influence of clinical symptoms of COVID-19 patients (P < 0.01). After controlling for various factors, multiple linear regression analysis revealed that an unbalanced constitution was significantly positively correlated with time to negative nucleic acid test results (P < 0.05). After controlling for various factors, logistic regression analysis revealed that an unbalanced constitution was closely related to the 7-day nucleic acid test conversion rate (odds ratio (OR): 0.53, 95% confidence interval (CI): 0.36-0.80, P < 0.05). After dividing the unbalanced constitution into deficiency constitution and non-deficiency constitution, the non-deficiency constitution was closely associated with the 7-day nucleic acid test conversion rate (OR = 0.45, 95% CI: 0.28-0.74, P < 0.05). Further analysis revealed that damp-heat constitution in the non-deficiency constitution was associated with the 7-day nucleic acid test conversion rate (OR = 0.33, 95% CI: 0.18-0.60, P < 0.05).Conclusion: In patients with COVID-19, an unbalanced constitution is associated with a longer time to negative nucleic acid test results and lower 7-day nucleic acid test conversion rates.
引用
收藏
页码:6333 / 6344
页数:12
相关论文
共 50 条
  • [21] Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant
    Flisiak, Robert
    Zarebska-Michaluk, Dorota
    Dobrowolska, Krystyna
    Rorat, Marta
    Rogalska, Magdalena
    Krynska, Justyna Anna
    Moniuszko-Malinowska, Anna
    Czupryna, Piotr
    Kozielewicz, Dorota
    Jaroszewicz, Jerzy
    Sikorska, Katarzyna
    Bednarska, Agnieszka
    Piekarska, Anna
    Rzymski, Piotr
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [22] Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients?
    Gunadi
    Hakim, Mohamad Saifudin
    Wibawa, Hendra
    Marcellus
    Setiawaty, Vivi
    Slamet
    Trisnawati, Ika
    Supriyati, Endah
    El Khair, Riat
    Iskandar, Kristy
    Afiahayati
    Siswanto
    Irene
    Anggorowati, Nungki
    Daniwijaya, Edwin Widyanto
    Nugrahaningsih, Dwi Aris Agung
    Puspadewi, Yunika
    Puspitarani, Dyah Ayu
    Tania, Irene
    Vujira, Khanza Adzkia
    Ardlyamustaqim, Muhammad Buston
    Gabriela, Gita Christy
    Eryvinka, Laudria Stella
    Nirmala, Bunga Citta
    Geometri, Esensi Tarian
    Darutama, Abirafdi Amajida
    Kuswandani, Anisa Adityarini
    Lestari
    Irianingsih, Sri Handayani
    Khoiriyah, Siti
    Lestari, Ina
    Ananda, Nur Rahmi
    Arguni, Eggi
    Nuryastuti, Titik
    Wibawa, Tri
    FRONTIERS IN MEDICINE, 2021, 8
  • [23] Clinical manifestations of pain in patients suffering from COVID-19 infected with Delta variant of SARS-Cov-2
    Mohammadian Erdi, Ali
    Zakavi, Minoo
    Amani, Mohammad
    Fooladi, Shahnaz
    Abedi, Ali
    FRONTIERS IN PAIN RESEARCH, 2023, 4
  • [24] Nirmatrelvir-ritonavir therapy and COVID-19 vaccination improve clinical outcomes of SARS-CoV-2 Omicron variant infection
    Qi, Tangkai
    Jin, Yinpeng
    Wang, He
    Liao, Yixin
    Liu, Tiefu
    Mao, Enqiang
    Li, Feng
    Li, Yinchuan
    Fan, Xiaohong
    Ling, Yun
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [25] Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
    Cui, Qianqian
    Shi, Zhengli
    Yimamaidi, Duman
    Hu, Ben
    Zhang, Zhuo
    Saqib, Muhammad
    Zohaib, Ali
    Gulnara, Baikadamova
    Yersyn, Mukhanbetkaliyev
    Hu, Zengyun
    Li, Shizhu
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [26] Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study
    Otsubo, Naoya
    Fukuda, Tatsuya
    Beppu, Hiroko
    Maki, Chisato
    Yasui, Fumihiko
    Hanawa, Tomohide
    Sugita, Chise
    Murakami, Masanori
    Yamada, Tetsuya
    Kohara, Michinori
    Wakai, Sachiko
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [27] Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant
    Ullrich, Fabian
    Hanoun, Christine
    Turki, Amin T.
    Liebregts, Tobias
    Breuckmann, Katharina
    Alashkar, Ferras
    Reinhardt, Hans Christian
    von Tresckow, Bastian
    von Tresckow, Julia
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (04) : 364 - 372
  • [28] Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study
    Pei, Lei
    Chen, Ying
    Zheng, Xiangtao
    Gong, Fangchen
    Liu, Wenbin
    Lin, Jingsheng
    Zheng, Ruizhi
    Yang, Zhitao
    Bi, Yufang
    Chen, Erzhen
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (02) : 182 - 189
  • [29] SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study
    Ali, Elrazi A.
    Khamees, Ibrahim
    Abu-Tineh, Mohammad
    Qasim, Hana
    Alshurafa, Awni
    Ahmed, Khalid
    Malkawi, Lujain
    Yassin, Mohamed A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [30] The impact of comorbidity status in COVID-19 vaccines effectiveness before and after SARS-CoV-2 omicron variant in northeastern Mexico: a retrospective multi-hospital study
    Camacho-Moll, Maria Elena
    Mata-Tijerina, Viviana Leticia
    Gutierrez-Salazar, Carlos Cuauhtemoc
    Silva-Ramirez, Beatriz
    Penuelas-Urquides, Katia
    Gonzalez-Escalante, Laura
    Escobedo-Guajardo, Brenda Leticia
    Cruz-Luna, Jorge Eleazar
    Corrales-Perez, Roberto
    Gomez-Garcia, Salvador
    Bermudez-de Leon, Mario
    FRONTIERS IN PUBLIC HEALTH, 2024, 12